RECRUITING

Impact of Personality on Adherence to Tyrosine Kinase Inhibitor Therapy in Pts w/Chronic Myeloid Leukemia

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

This is an observational pilot study to examine the association between a patient's personality and adherence to tyrosine kinase inhibitor therapy in patients with chronic myeloid leukemia.

Official Title

Impact of Personality on Adherence to Tyrosine Kinase Inhibitor Therapy in Patients With Chronic Myeloid Leukemia

Quick Facts

Study Start:2024-01-25
Study Completion:2026-01
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT06229860

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:No
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. * 18 years of age or older
  2. * Diagnosed with chronic myeloid leukemia (CML) and in the chronic phase (CML-CP)
  3. * Currently being treated with one of four cancer medications - imatinib, dasatinib, bosutinib, or nilotinib
  4. * A patient at the UCI Chao Family Comprehensive Cancer Center (CFCCC), or
  5. * A member of a patient support group organized by the CML Buster Foundation
  6. * Do not meet any of the criteria listed under "Exclusion Requirements"
  1. * Unable to read and speak English
  2. * Impaired decisional capacity to consent

Contacts and Locations

Study Contact

Chao Family Comprehensive Cancer Center University of California, Irvine
CONTACT
1-877-827-8839
ucstudy@uci.edu
University of California Irvine Medical
CONTACT

Principal Investigator

Mahtab Jafari, Pharm.D
PRINCIPAL_INVESTIGATOR
Chao Family Comprehensive Cancer Center

Study Locations (Sites)

Chao Family Comprehensive Cancer Center University of California, Irvine
Orange, California, 92868
United States

Collaborators and Investigators

Sponsor: University of California, Irvine

  • Mahtab Jafari, Pharm.D, PRINCIPAL_INVESTIGATOR, Chao Family Comprehensive Cancer Center

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2024-01-25
Study Completion Date2026-01

Study Record Updates

Study Start Date2024-01-25
Study Completion Date2026-01

Terms related to this study

Additional Relevant MeSH Terms

  • Chronic Myeloid Leukemia
  • Chronic Phase Chronic Myelogenous Leukemia